Human Viruses: Diseases, Treatments and Vaccines (PDF)

SHAMIM I AHMAD after obtaining his Master's degree in Botany from Patna University, India and his Ph.D. in Molecular Genetics from Leicester University, England, in 1972 he joined Nottingham Trent University as grade-1 Lecturer and subsequently promoted to Senior Lecturer post. Here, after serving for 35 years, he took an early retirement although continuing delivering certain lectures. His research interest culminated in collaboration and visits to the University of Missouri, Columbia, USA; University of Osaka, Japan; University of Copenhagen, Denmark; Institute of Genetics and Industrial Microorganisms, Moscow, Russia; Academic Institute of Photographic Chemistry, Beijing, China; University of Leiden, Holland; Imperial Chemical Industry, Bellingham, UK; CNRS (Centre National de la Recherche Scientifique) Gif-Sur-Yvette, France; PHLS (Public Health Laboratory Services), Salisbury, England, and University of Manila, Philippines. Also has presented a number of oral presentations in international meetings and symposia. His active research expanded for over 3 decades and carried out in different areas of molecular biology/genetics including thymineless death in bacteria, genetic control of nucleotide catabolism, development of anti-AIDs drug, control of microbial infection of burns, phages of thermophilic bacteria, and microbial flora of Chernobyl after the accident at its nuclear power station. His continuing umbrella research is on DNA damage, repair and mutagenesis and UV photoreaction of biological and non-biological compounds producing reactive oxygen species: implications on human health. His latest popular publication is "5-fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the coronavirus, COVID-19 infection". He is the believer that the phage therapy remains as an alternative to the future treatment of bacterial infections, especially those developing resistant to multiple antibiotics.
In 2003, he